Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Phosphopentobarbital vs Propofol for Sedation in Painless Endoscopy in Liver Cirrhosis
ChiCTR2500097793Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium phosphopentobarbital in Cirrhosis (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: RASS score at 10 minutes after administration. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
sodium phosphopentobarbital
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ChiCTR2500097793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097793.